{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:27:26Z","timestamp":1789064846399,"version":"build-2803163510"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/asj\/sjx005","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T14:15:16Z","timestamp":1491574516000},"page":"S45-S58","source":"Crossref","is-referenced-by-count":64,"title":["New Uses of AbobotulinumtoxinA in Aesthetics"],"prefix":"10.1093","volume":"37","author":[{"given":"Joel","family":"Schlessinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joely","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"issue":"3 Pt 2","key":"key\n\t\t\t\t20170407101037_CIT0001","first-page":"510","article-title":"The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine\u2014a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practice","volume":"39","year":"2013","journal-title":"Dermatol Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0002","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fsc.2015.01.010","article-title":"The role of neurotoxins in the periorbital and midfacial areas","volume":"23","year":"2015","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"1","key":"key\n\t\t\t\t20170407101037_CIT0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1473-2165.2011.00593.x","article-title":"Advances in the use of botulinum neurotoxins in facial esthetics","volume":"11","year":"2012","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"key\n\t\t\t\t20170407101037_CIT0004","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1524-4725.2011.02007.x","article-title":"Aesthetic dermatology for aging ethnic skin","volume":"37","year":"2011","journal-title":"Dermatol Surg"},{"issue":"12","key":"key\n\t\t\t\t20170407101037_CIT0005","doi-asserted-by":"crossref","first-page":"e115690","DOI":"10.1371\/journal.pone.0115690","article-title":"Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial","volume":"9","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0006","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/229255031502300402","article-title":"Botulinum toxin for the prevention and healing of wound scars: a systematic review of the literature","volume":"23","year":"2015","journal-title":"Plast Surg (Oakv)"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bjps.2012.09.012","article-title":"Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study","volume":"66","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-0032-1325641","article-title":"Botulinum toxin to minimize facial scarring","volume":"28","year":"2012","journal-title":"Facial Plast Surg"},{"key":"key\n\t\t\t\t20170407101037_CIT0009","first-page":"103","article-title":"Management of keloids and hypertrophic scars: current and emerging options","volume":"6","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000342125","article-title":"Botulinum toxin A for the treatment of keloids","volume":"25","year":"2012","journal-title":"Skin Pharmacol Physiol"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0011","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00266-011-9690-3","article-title":"Botulinum toxin type a inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar","volume":"35","year":"2011","journal-title":"Aesthetic Plast Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1742-481X.2012.01118.x","article-title":"Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings","volume":"11","year":"2014","journal-title":"Int Wound J"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0013","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coms.2010.01.007","article-title":"Screening for psychiatric problems in the orofacial trauma setting","volume":"22","year":"2010","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0014","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bjoms.2005.10.010","article-title":"Anxiety and self-consciousness in patients with facial lacerations one week and six months later","volume":"44","year":"2006","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"1","key":"key\n\t\t\t\t20170407101037_CIT0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PRS.0b013e3181a80747","article-title":"Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys","volume":"124","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0016","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/SAP.0000000000000268","article-title":"Botulinum toxin type A inhibits \u03b1-smooth muscle actin and myosin II expression in fibroblasts derived from scar contracture","volume":"77","year":"2016","journal-title":"Ann Plast Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0017","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/molecules17022169","article-title":"Effects of botulinum toxin type a on collagen deposition in hypertrophic scars","volume":"17","year":"2012","journal-title":"Molecules"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0018","doi-asserted-by":"crossref","first-page":"171e","DOI":"10.1097\/PRS.0000000000001438","article-title":"Effect of botulinum toxin type A on differentiation of fibroblasts derived from scar tissue","volume":"136","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0019","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00266-009-9423-z","article-title":"Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report","volume":"34","year":"2010","journal-title":"Aesthetic Plast Surg"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/labinvest.2008.36","article-title":"Regulation of scar formation by vascular endothelial growth factor","volume":"88","year":"2008","journal-title":"Lab Invest"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0021","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/lary.24456","article-title":"Effects of botulinum toxin A on patient-specific keloid fibroblasts in vitro","volume":"124","year":"2014","journal-title":"Laryngoscope"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0022","doi-asserted-by":"crossref","first-page":"e0151627","DOI":"10.1371\/journal.pone.0151627","article-title":"Botulinum toxin type A and the prevention of hypertrophic scars on the maxillofacial area and neck: a meta-analysis of randomized controlled trials","volume":"11","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0023","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1177\/229255030901700313","article-title":"Use of botulinum toxin in cheiloplasty: A new method to decrease tension","volume":"17","year":"2009","journal-title":"Can J Plast Surg"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0024","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/PRS.0000000000000416","article-title":"Botulinum toxin to improve results in cleft lip repair","volume":"134","year":"2014","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/wrr.12204","article-title":"Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial","volume":"22","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0026","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/SAP.0000000000000625","article-title":"Donor site aesthetic enhancement with preoperative botulinum toxin in forehead flap nasal reconstruction","volume":"77","year":"2016","journal-title":"Ann Plast Surg"},{"issue":"8","key":"key\n\t\t\t\t20170407101037_CIT0027","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4065\/81.8.1023","article-title":"Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study","volume":"81","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0028","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1097\/01.prs.0000209944.45949.d1","article-title":"Use of botulinum toxin type A to prevent widening of facial scars","volume":"117","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1524-4725.2008.34407.x","article-title":"Use of intraoperative botulinum toxin in facial reconstruction","volume":"35","year":"2009","journal-title":"Dermatol Surg"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bjps.2012.08.042","article-title":"Keloid scars and treatment with botulinum toxin type A: the Belfast experience","volume":"66","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jocd.12134","article-title":"Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial","volume":"14","year":"2015","journal-title":"J Cosmet Dermatol"},{"issue":"9","key":"key\n\t\t\t\t20170407101037_CIT0032","first-page":"978","article-title":"A novel, multistep, combination facial rejuvenation procedure for treatment of the whole face with incobotulinumtoxinA, and two dermal fillers- calcium hydroxylapatite and a monophasic, polydensified hyaluronic acid filler","volume":"12","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0033","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/14764172.2012.712700","article-title":"A skincare containing retinol adenosine and hyaluronic acid optimises the benefits from a type A botulinum toxin injection","volume":"14","year":"2012","journal-title":"J Cosmet Laser Ther"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0034","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jocd.12082","article-title":"Remodeling of periorbital, temporal, glabellar, and crow\u2019s feet areas with hyaluronic acid and botulinum toxin","volume":"13","year":"2014","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0035","first-page":"191","article-title":"Optimizing facial rejuvenation outcomes by combining poly-L-lactic acid, hyaluronic acid, calcium hydroxylapatite, and neurotoxins: two case studies","volume":"13","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"key\n\t\t\t\t20170407101037_CIT0036","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1097\/DSS.0000000000000548","article-title":"Patient satisfaction and efficacy of full-facial rejuvenation using a combination of botulinum toxin type A and hyaluronic acid filler","volume":"41","year":"2015","journal-title":"Dermatol Surg"},{"issue":"4 Suppl","key":"key\n\t\t\t\t20170407101037_CIT0037","first-page":"S81","article-title":"Correcting age-related changes in the face by use of injectable fillers and neurotoxins","volume":"33","year":"2014","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0038","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1090820X11411579","article-title":"Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A","volume":"31","year":"2011","journal-title":"Aesthet Surg J"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jocd.12059","article-title":"Treatment of forehead\/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial","volume":"12","year":"2013","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4161\/derm.22804","article-title":"Skin anti-aging strategies","volume":"4","year":"2012","journal-title":"Dermatoendocrinol"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0041","doi-asserted-by":"crossref","first-page":"756","DOI":"10.5021\/ad.2015.27.6.756","article-title":"Combined treatment with botulinum toxin and 595-nm pulsed dye laser for traumatic scarring","volume":"27","year":"2015","journal-title":"Ann Dermatol"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0042","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14764170410023767","article-title":"Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing","volume":"6","year":"2004","journal-title":"J Cosmet Laser Ther"},{"issue":"8","key":"key\n\t\t\t\t20170407101037_CIT0043","first-page":"1062","article-title":"The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study","volume":"34","year":"2008","journal-title":"Dermatol Surg"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0044","first-page":"355","article-title":"The effect of full-face broadband light treatments alone and in combination with bilateral crow\u2019s feet Botulinum toxin type A chemodenervation","volume":"30","year":"2004","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170407101037_CIT0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphotobiol.2014.03.009","article-title":"Anti-photoaging potential of Botulinum toxin type A in UVB-induced premature senescence of human dermal fibroblasts in vitro through decreasing senescence-related proteins","volume":"133","year":"2014","journal-title":"J Photochem Photobiol B"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0046","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jamafacial.2015.0376","article-title":"Alterations in the elasticity, pliability, and viscoelastic properties of facial skin after injection of onabotulinum toxin A","volume":"17","year":"2015","journal-title":"JAMA Facial Plast Surg"},{"issue":"9","key":"key\n\t\t\t\t20170407101037_CIT0047","first-page":"990","article-title":"Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment","volume":"10","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0048","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1467-2494.2006.00349.x","article-title":"Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique","volume":"28","year":"2006","journal-title":"Int J Cosmet Sci"},{"key":"key\n\t\t\t\t20170407101037_CIT0049","doi-asserted-by":"crossref","first-page":"92S","DOI":"10.1097\/PRS.0000000000001827","article-title":"Microbotox of the lower face and neck: evolution of a personal technique and its clinical effects","volume":"136","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00266-013-0134-0","article-title":"Accordion wrinkle treatment through the targeted use of botulinum toxin injections","volume":"38","year":"2014","journal-title":"Aesthetic Plast Surg"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0051","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.anplas.2012.02.001","article-title":"Griffose faciale: traitement des rides dynamiques du visage par injections dermiques simultan\u00e9es de toxine botulique A et d\u2019acide hyaluronique","volume":"57","year":"2012","journal-title":"Ann Chir Plast Esthet"},{"issue":"1","key":"key\n\t\t\t\t20170407101037_CIT0052","first-page":"38","article-title":"Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines","volume":"11","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0053","first-page":"73","article-title":"Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion","volume":"117","year":"2008","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0054","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/DSS.0000000000000646","article-title":"Prospective randomized split-face comparative study between topical botulinum toxin A surface application and local injection for Crow\u2019s feet","volume":"42","year":"2016","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170407101037_CIT0055","first-page":"3853754","article-title":"The efficacy and safety of fractional CO2 laser combined with topical type A botulinum toxin for facial rejuvenation: a randomized controlled split-face study","volume":"2016","year":"2016","journal-title":"Biomed Res Int"},{"key":"key\n\t\t\t\t20170407101037_CIT0056","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/01.DSS.0000452642.83894.ab","article-title":"Prospective randomized controlled study to determine the effect of topical application of botulinum toxin A for crow\u2019s feet after treatment with ablative fractional CO2 laser","volume":"41","year":"2015","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170407101037_CIT0057"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0058","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/PRS.0000000000001032","article-title":"The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines","volume":"135","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"8","key":"key\n\t\t\t\t20170407101037_CIT0059","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/1090820X11422809","article-title":"Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections","volume":"31","year":"2011","journal-title":"Aesthet Surg J"},{"issue":"1","key":"key\n\t\t\t\t20170407101037_CIT0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PRS.0000000000000831","article-title":"Nonsurgical periorbital and brow rejuvenation","volume":"135","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0061","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00266-014-0445-9","article-title":"Effectiveness of botulinum toxin (type-A) administered by the fixed-site dosing approach versus the muscle area identification","volume":"39","year":"2015","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0062","doi-asserted-by":"crossref","first-page":"209e","DOI":"10.1097\/PRS.0000000000000371","article-title":"Classification of masseter hypertrophy for tailored botulinum toxin type A treatment","volume":"134","year":"2014","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0063","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","article-title":"Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study","volume":"124","author":"Reloxin Investigational Group","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0064","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09546634.2012.672706","article-title":"Intralesional therapy for psoriasis","volume":"24","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"key\n\t\t\t\t20170407101037_CIT0065","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/DSS.0000000000000277","article-title":"Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea","volume":"41","year":"2015","journal-title":"Dermatol Surg"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0066","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000368773","article-title":"Botulinum toxin for the treatment of refractory erythema and flushing of rosacea","volume":"230","year":"2015","journal-title":"Dermatology"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0067","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clindermatol.2004.03.004","article-title":"Acne and sebaceous gland function","volume":"22","year":"2004","journal-title":"Clin Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0068","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.06.009","article-title":"Regulation of lipid production by acetylcholine signalling in human sebaceous glands","volume":"72","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"9","key":"key\n\t\t\t\t20170407101037_CIT0069","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size","volume":"7","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"3 Pt 1","key":"key\n\t\t\t\t20170407101037_CIT0070","first-page":"443","article-title":"Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin","volume":"39","year":"2013","journal-title":"Dermatol Surg"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0071","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10286-002-0026-x","article-title":"The role of gustatory flushing in Frey\u2019s syndrome and its treatment with botulinum toxin type A","volume":"12","year":"2002","journal-title":"Clin Auton Res"},{"issue":"12","key":"key\n\t\t\t\t20170407101037_CIT0072","first-page":"e76","article-title":"A new treatment regimen for rosacea: onabotulinumtoxinA","volume":"11","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0073","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-3083.2007.02457.x","article-title":"Botulinum toxin type-A for the treatment of inverse psoriasis","volume":"22","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"key\n\t\t\t\t20170407101037_CIT0074","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/jid.2012.60","article-title":"Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model","volume":"132","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"11","key":"key\n\t\t\t\t20170407101037_CIT0075","first-page":"1407","article-title":"Efficacy of botulinum neurotoxin type A for treating recalcitrant plaque psoriasis","volume":"13","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0076","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1525-1470.2010.01102.x","article-title":"Fox-Fordyce disease exacerbated by hyperhidrosis","volume":"27","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0077","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2133.2010.09927.x","article-title":"Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita","volume":"163","year":"2010","journal-title":"Br J Dermatol"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0078","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1524-4725.2000.99278.x","article-title":"Botulinum toxin type A for the treatment of axillary Hailey-Hailey disease","volume":"26","year":"2000","journal-title":"Dermatol Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101037_CIT0079","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bjd.14180","article-title":"Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A","volume":"174","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0080","first-page":"E14","article-title":"Recalcitrant Hailey-Hailey disease responds to oral tacrolimus and botulinum toxin type A","volume":"96","year":"2015","journal-title":"Cutis"},{"issue":"5","key":"key\n\t\t\t\t20170407101037_CIT0081","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1590\/S0365-05962010000500021","article-title":"Hailey-Hailey disease treatment with Botulinum toxin type A","volume":"85","year":"2010","journal-title":"An Bras Dermatol"},{"issue":"1","key":"key\n\t\t\t\t20170407101037_CIT0082","first-page":"68","article-title":"Successful botulinum toxin (onabotulinumtoxinA) treatment of Hailey-Hailey disease","volume":"14","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0083","first-page":"532","article-title":"[Botulinum toxin A for the treatment of familial benign pemphigus]","volume":"103","year":"2012","journal-title":"Actas Dermosifiliogr"},{"issue":"12","key":"key\n\t\t\t\t20170407101037_CIT0084","first-page":"13030\/qt6z35r538","article-title":"Benign familial pemphigus (Hailey-Hailey disease)","volume":"21","year":"2015","journal-title":"Dermatol Online J"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/09546630801955135","article-title":"Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey-Hailey disease","volume":"19","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"9","key":"key\n\t\t\t\t20170407101037_CIT0086","first-page":"1861","article-title":"Autoimmune bullous dermatoses: a review","volume":"65","year":"2002","journal-title":"Am Fam Physician"},{"issue":"1","key":"key\n\t\t\t\t20170407101037_CIT0087","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2340\/00015555-2178","article-title":"Botulinum toxin A: an effective treatment for linear immunoglobulin A bullous dermatosis located in the Axillae","volume":"96","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"key\n\t\t\t\t20170407101037_CIT0088","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.2005.07115.x","article-title":"Treatment of pachyonychia congenita with plantar injections of botulinum toxin","volume":"154","year":"2006","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20170407101037_CIT0089","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxicon.2013.05.011","article-title":"A closer look to botulinum neurotoxin type A-induced analgesia","volume":"71","year":"2013","journal-title":"Toxicon"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/11534510-000000000-00000","article-title":"Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects","volume":"24","year":"2010","journal-title":"BioDrugs"},{"issue":"3","key":"key\n\t\t\t\t20170407101037_CIT0091","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-016-0545-0","article-title":"Botulinum toxin: pharmacology and therapeutic roles in pain states","volume":"20","year":"2016","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"key\n\t\t\t\t20170407101037_CIT0092","first-page":"785","article-title":"Neurologic uses of botulinum neurotoxin type A","volume":"3","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"key\n\t\t\t\t20170407101037_CIT0093","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","article-title":"Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms","volume":"59","year":"2000","journal-title":"Biochem Pharmacol"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/asj\/article-pdf\/37\/suppl_1\/S45\/11165308\/sjx005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:47:45Z","timestamp":1569008865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article-lookup\/doi\/10.1093\/asj\/sjx005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":93,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,4,7]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjx005","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}